Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
6,999,586
-
Total 13F shares
-
7,235
-
Share change
-
+7,235
-
Total reported value
-
$30,532
-
Price per share
-
$4.24
-
Number of holders
-
9
-
Value change
-
+$30,532
-
Number of buys
-
9
Institutional Holders of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) as of Q1 2024
As of 31 Mar 2024,
TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,235 shares.
The largest 9 holders included
Qube Research & Technologies Ltd, UBS Group AG, Tower Research Capital LLC (TRC), CIBC Private Wealth Group, LLC, BlackRock Inc., MORGAN STANLEY, WELLS FARGO & COMPANY/MN, Allworth Financial LP, and TUCKER ASSET MANAGEMENT LLC.
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.